02289nam a2200289 4500 11003 9789291685615 11003 20180830d2012 y0pory50 ba eng Prisons and drugs in Europe the problem and responses EMCDDA Selected issues European Monitoring Centre for Drugs and Drug Addiction Luxembourg Pubications Office of the European Union 2012 31 p. il. 30 cm This Selected issue starts off by reviewing the available data on drug use among prison populations in Europe, focusing on injecting drug use and other health risk behaviours. Major health risks for drug-using prisoners, including blood-borne infections and infections that can affect all prisoners equally, such as tuberculosis, are discussed. Also mentioned is the role of prison environments, where overcrowding and unsanitary conditions are not uncommon, and the higher-than-average occurrence of psychiatric problems among prisoners. The first section concludes by describing the increased risk of death among prisoners, both in custody and after release. The second part of the report focuses on responses to the health needs of drug-using prisoners in European countries. The study looks at how the internationally recognised rights of prisoners and the European and international rules that set standards for the care of prisoners apply to those with drug problems. The administration of prison healthcare in European countries is examined, and national policies are reviewed. This is followed by an overview of the available information on drug-related service provision in Europe, from prison entry to prison release, addressing counselling, treatment of drug dependence and the prevention of infectious diseases and drug overdose MEDICINA 1408 MEDICINA NA PRISÃO 104985 ADMINISTRAÇÃO PENITENCIÁRIA 560 PRESO 942 PREVENÇÃO 1401 DOENÇAS TRANSMISSÍVEIS 4927 HEPATITE 104361 SIDA 4926 UNIÃO EUROPEIA 100 European Monitoring Centre for Drugs and Drug Addiction 11925 61EUR 0 61EUR 2021-12-17 2634 14200 DGRSP DGRSP DGRSP26341110488 61EUR 2021-12-17 0 MO oferta